Following up tumor-specific regulatory T cells in cancer patients.
INSERM, U1015; Villejuif, France ; Institut Gustave Roussy; Villejuif, France ; CICBT507; Villejuif, France ; Université Paris Sud; Le Kremlin Bicêtre, France.
Laurence
L
Zitvogel
Corinne
C
Tanchot
Clemence
C
Granier
Eric
E
Tartour
cancer vaccine; immunomonitoring; immunosuppression; regulatory T cell; tumor antigen